Purchase Order 75D30123P17601

Award Date 8/25/23
Potential Completion Date 9/1/23
Potential Value $11K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Revvity Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Shelton, CT 06484, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $249,015.99 firm-fixed-price purchase order contract to Revvity Health Sciences, Inc. for the PERKIN ELMORE-SCICLONE G3 NGSX medical imaging product. The contract will be performed in Shelton, Connecticut and has a completion date of October 15, 2022. Revvity Health Sciences, Inc. is a for-profit manufacturer of goods that provides a wide variety of medical devices and equipment, as well as...
The Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) awarded a firm fixed-price purchase order worth $137,053.70 to Revvity Health Sciences, Inc. for the PERKINELMER CHEMAGIC 360 INSTRUMENT. The contract, which had a completion date of July 30, 2021, was awarded on June 30, 2017. The place of performance was in Atlanta, Georgia. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and laboratory equipment that has...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $19,270 purchase order to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, for a BIOQULE next-generation sequencing system. The firm fixed price contract runs from July 2, 2023 through July 31, 2023 and will be performed in Shelton, Connecticut. No subcontractors or set aside designations were identified. The sequencing technology will support CDC's...
This federal contract award to Revvity Health Sciences, Inc. is a firm fixed-price Purchase Order valued at $20,246.40 with the Centers for Disease Control and Prevention (CDC) for laboratory equipment and services. The award has a period of performance through March 24, 2023. Revvity Health Sciences, Inc. is a subsidiary of the parent company Revvity Inc., which provides medical imaging products and services to federal agencies through prime contracts and subcontracts. This award does not...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order to Revvity Health Sciences, Inc. for the delivery of a SCICLONE G3 NGSX HT WORKSTATION laboratory instrument. The contract has a potential value of $242,491.55 and a period of performance through September 30, 2020. No set-aside designation was used for this award. Revvity Health Sciences, Inc. is a for-profit manufacturer that provides a range of medical...
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for the purchase of a Zephyr G3 Next Generation Sequencing (NGS) system for the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). The firm-fixed-price purchase order, awarded on August 2, 2016, has a ceiling value of $109,133.21 and a completion date of August 1, 2017. The contract does not have a set-aside...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a one-year, firm fixed price purchase order valued at twenty-one thousand, five hundred seven dollars and eighty-four cents ($21,507.84) by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract calls for Perkin Elmer service delivery in support of CDC programs. Performance will take place in Shelton, Connecticut. The award draws from CDC funding to...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $222,217.00 firm fixed-price purchase order contract to Revvity Health Sciences, Inc. for genetic screening services. The contract was awarded on July 13, 2021 with a completion date of September 30, 2021. Revvity Health Sciences, Inc. is a for-profit manufacturer that provides medical imaging products and services to federal agencies through prime contracts and subcontracts. The company's...
This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc. (a subsidiary of PerkinElmer, Inc.) for the provision of laboratory equipment. The contract has a ceiling value of $98,683.66 and a period of performance ending on July 3, 2017. The contract was not set aside for any specific business category. Revvity Health Sciences is a for-profit manufacturer that has received previous prime contract awards and...
This federal contract award to Revvity Health Sciences, Inc. (a subsidiary of Revvity Inc.) was issued by the Centers for Disease Control and Prevention (CDC) for the provision of a SCICLONE NGSX WORKSTATION, a medical imaging product. The $209,609.14 firm fixed-price contract has a performance period ending on May 8, 2015. The contract was not set aside for any specific business type. Revvity Health Sciences has a history of providing a wide range of medical devices and laboratory equipment...

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $10,530.15 Firm Fixed Price Purchase Order to Revvity Health Sciences, Inc. for a PERKINELMER BIOQULE NGS AUTOMATED LIBRARY PREP INSTRUMENT. The contract has a completion date of September 1, 2023 and was awarded on August 25, 2023. This award does not appear to have a set-aside designation. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and services, and is a subsidiary of the parent company Revvity Inc. The federal contract supports the CDC's scientific research initiatives, likely related to next-generation sequencing (NGS) workflows.

Generated 4/12/24, 11:20 AM